Search for: "Robert C. Andrews" Results 41 - 60 of 860
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jul 2023, 1:03 pm by Ryan Goodman
Andrew Restuccia and Ted Mann, “Jan. 6, 2021: How It Unfolded - A Minute-by-Minute Look,” Wall Street Journal (Feb. 12, 2021) 5. [read post]
However, the traditional “surviving patent” approach according to Harnkatheterset is now under some scrutiny: A referral to the CJEU by Munich I Regional Court resulted in the decision C-44/21 Phoenix Contact v Harting, in which it was held that a “surviving patent only” approach is incompatible with the Enforcement Directive. [read post]
3 Jul 2023, 4:07 am by INFORRM
Canada Google has announced that it will block news links in Canada in response to the mandated payment for links approach established in Bill C-18. [read post]
30 Jun 2023, 1:29 am by Kluwer Patent blogger
The Munich section will be competent for chemistry, metallurgy (Section C), without supplementary protection certificates and (F) mechanical engineering, lighting, heating, weapons, blasting. [read post]
12 Jun 2023, 1:45 pm by Kalvis Golde
In dissent from that ruling, Judge Andrew Oldham wrote, “there’s zero difficulty or complexity in figuring out whether it was animus or [Gonzalez’s] purportedly criminal conduct that caused her arrest. [read post]
10 Jun 2023, 8:32 am by Kluwer Patent blogger
According to the proposal of the three member states, Milan will be competent for IPC Section A patents (human necessities), the Munich section  also be competent for IPC Section C patents (chemistry and metallurgy) and the Paris seat for SPCs from Sections A and C. [read post]
9 Jun 2023, 4:00 am by Jim Sedor
Robert Menendez helped a wealthy Florida doctor in exchange for lavish gifts. [read post]
7 Jun 2023, 12:06 am by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]
3 Jun 2023, 7:24 pm by Bill Marler
An Introduction to Salmonella Bacteria Salmonella is a bacterium that causes one of the most common enteric (intestinal) infections in the United States – salmonellosis. [read post]
2 Jun 2023, 12:08 pm by Bill Marler
Subgroups A, B, C and D have historically been treated as species: subgroup A for Shigella dysenteriae; subgroup B for Shigella flexneri; subgroup C for Shigella boydii and subgroup D for Shigella sonnei. [read post]
29 May 2023, 11:43 am by Kluwer Patent blogger
While the start of the Unitary Patent system will celebrated tomorrow at the UPC in Luxembourg and on Thursday with the EPO event “Welcoming the Unitary Patent System – A new era for innovation in Europe”, tomorrow also a conference will be held in Brussels (4.30 – 6.30 pm) with a distinctly more critical title: The Unitary Patent Package: a start on shaky tracks? [read post]
20 May 2023, 6:29 am by Thorsten Bausch (Hoffmann Eitle)
Many pharma patents, particularly substance patents, are classified in IPC main class C. [read post]
16 May 2023, 12:55 am by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]
4 May 2023, 9:05 pm by renholding
The world hit a record level of carbon emissions in 2022[24] and is projected to warm by 2.5-3°C by 2100.[25]Estimates of climate-related losses include: 18 percent global GDP loss by 2050 under a business-as-usual case (Swiss Re)[26]; nearly 25 percent cumulative loss in global output in the next two decades if mitigation actions are not taken (BlackRock)[27]; 10 percent GDP loss by 2050 for temperature increases above 3°C (Vanguard)[28]; 15-20 percent cumulative reduction… [read post]